Dr. Sallam is an Associate Professor of Medicine at the David Geffen School of Medicine at UCLA and a clinical cardiologist at Ronald Reagan UCLA Medical Center. He is a member of the Atherosclerosis Research Unit and Cardiovascular Theme Initiative at UCLA. Dr. Sallam graduated from the University of California, Irvine School of Medicine. He completed residency and chief residency training in Internal Medicine at Yale, followed by Cardiology fellowship training at UCLA. Dr. Sallam graduated from the STAR program at UCLA earning a Ph.D. in Molecular, Cellular and Integrative Physiology in the HHMI Lab of Peter Tontonoz. He joined the UCLA faculty after fellowship, where his research investigates the role of novel transcription factor regulatory circuits in cardiometabolic disease.
In 2015, Dr. Sallam has been awarded the Lauren B. Leichtman and Arthur E. Levine Cardiovascular Discovery Fund investigatorship at UCLA. Dr. Sallam is the recipient of an NIH K Award, American College of Cardiology Presidential Career Development Award, American Heart Association Early Career Investigator recognition, and American Society for Clinical Investigation Young Investigator Award. Dr. Sallam currently serves as co-director of the UCLA Center for Cholesterol Management and Assistant Director of the UCLA Specialty Training and Advanced Research (STAR) Program.
Laboratory of Tamer Sallam M.D., Ph.D. medschool.ucla.edu/star uclahealth.org/heart
Laboratory of Tamer Sallam M.D., Ph.D.
Gene therapy using ‘junk DNA’ could lower risk for heart disease - UCLA Health
Familial Hypercholesterolemia: “Junk” RNA May Facilitate Gene Therapy - MedicalResearch.com
LXR maintains cholesterol balance through a noncoding RNA - ScienceSignaling
Note: News links may expire without notice.
Learn more about myUCLAhealth